MediciNova, Inc. Profile Avatar - Palmy Investing

MediciNova, Inc.

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inf…

Biotechnology
US, La Jolla [HQ]

News

Theses · Events · Sentiments
End of MNOV's Analysis
CIK: 1226616 CUSIP: 58468P206 ISIN: US58468P2065 LEI: - UEI: -
Secondary Listings
MNOV has no secondary listings inside our databases.